| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 4022 | 2011 |
| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 1542 | 2012 |
| ARID1A mutations in endometriosis-associated ovarian carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1325 | 2010 |
| Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ... Nature 461 (7265), 809-813, 2009 | 1114 | 2009 |
| Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011 | 962 | 2011 |
| Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 … FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ... PLoS medicine 7 (5), 2010 | 835 | 2010 |
| Ovarian carcinoma subtypes are different diseases: implications for biomarker studies M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ... PLoS medicine 5 (12), 2008 | 719 | 2008 |
| Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma C Tognon, SR Knezevich, D Huntsman, CD Roskelley, N Melnyk, ... Cancer cell 2 (5), 367-376, 2002 | 680 | 2002 |
| Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012 | 664 | 2012 |
| Familial gastric cancer: overview and guidelines for management C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ... Journal of medical genetics 36 (12), 873-880, 1999 | 592 | 1999 |
| Mutation of FOXL2 in granulosa-cell tumors of the ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 574 | 2009 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 542 | 2018 |
| Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research RC Fitzgerald, R Hardwick, D Huntsman, F Carneiro, P Guilford, V Blair, ... Journal of medical genetics 47 (7), 436-444, 2010 | 541 | 2010 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 505 | 2018 |
| Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7 (1), 134, 2007 | 489 | 2007 |
| Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors Y Lou, PC McDonald, A Oloumi, S Chia, C Ostlund, A Ahmadi, A Kyle, ... Cancer research 71 (9), 3364-3376, 2011 | 480 | 2011 |
| MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 476 | 2011 |
| Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations DG Huntsman, F Carneiro, FR Lewis, PM MacLeod, A Hayashi, ... New England Journal of Medicine 344 (25), 1904-1909, 2001 | 465 | 2001 |
| deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data A McPherson, F Hormozdiari, A Zayed, R Giuliany, G Ha, MGF Sun, ... PLoS computational biology 7 (5), 2011 | 453 | 2011 |
| EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ... Cell 115 (5), 523-535, 2003 | 449 | 2003 |
